Background: European Organization for Research and Treatment quality of life (QOL) questionnaire (QLQ-C30) has been used frequently and many language versions have been developed, including the simplified Chinese version. It is important to study psychometric properties of the simplified Chinese version from the clinical standpoint.
Of the instrument systems mentioned above, the QLQs from EORTC were developed to assess the health-related QOL of cancer patients participating in international clinical trials. The core questionnaire of the system, QLQ-C30, is used to measure QOL for all cancer patients. By adding specific modules into QLQ-C30, EORTC developed several cancerspecific questionnaires, such as the QLQ-C30 and QLQ-BR23 for breast cancer [6] and QLQ-C30 and QLQ-LC13 for lung cancer [7] . The current QLQ-C30 (V3.0) is a 30-item cancerspecific scale addressing various aspects of QOL classified into 15 domains including five functional subscales (physical, role, emotional, cognitive, and social), three multi-item symptom subscales (fatigue, pain, and nausea/vomiting), a global health/QOL subscale, and six single items addressing various symptoms and perceived financial impact. All items use a four-point Likert scale, namely, not at all, a little, quite a bit, and very much, except for the global health status (QL)/ QOL (Q29 and Q30), in which a seven-point scale is used. Standardized scores for all 15 domains ranged from 0 to 100, with a higher score indicating better QOL for the functional and global health domains and worse QOL (a greater degree of symptoms) for the symptom domains.
Many research studies [8] [9] [10] have confirmed that QLQ-C30 is an excellent QOL instrument with good psychometric properties. For example, Kemmler et al. [9] reported Cronbach's a coefficients ranging from 0.562 to 0.941, with 0.769 for physical functioning (PF), 0.759 for social functioning (SF), 0.797 for emotional functioning (EF), 0.864 for role functioning (RF), 0.661 for cognitive functioning (CF), and 0.941 for QL. Luo et al. [10] studied its validation in Singapore and the results showed that Spearman's correlations between the QLQ-C30 and SF-36 scales assessing similar dimensions of health related quality of life ranged from 0.35 to 0.67, subjects with mild symptoms had better scores than those with severe symptoms for all six QLQ-C30 QOL scales (P < 0.05 for five scales), and Cronbach's a ranged from 0.19 for the cognitive functioning scale to 0.91 for the global QOL scale.
As the QLQ-C30 is of greatest importance (since it serves as the core of the system), it has been translated into >54 language versions including Chinese. In particular, EORTC developed two versions of QLQ-C30 (the simplified Chinese version for Mainland China and the traditional Chinese version for Taiwan and Hong Kong) according to strict translation procedures including forward translation, back translation, and cultural adaptation [11] [12] [13] [14] . The simplified Chinese version was developed using simplified Chinese characters that are used in Mainland China. Chie et al. [11] [12] [13] reported the validation of the traditional Chinese version of QLQ-C30 (V3.0) from data in patients with lung cancer, breast cancer, and nasopharyngeal carcinoma, respectively. Zhao and Kanda [14] presented the translation procedures and validation of the simplified Chinese version of QLQ-C30 (V2.0). Psychometrics of the current simplified Chinese version of QLQ-C30 (V3.0) must be confirmed in field tests before it can be used broadly in China. The translation procedures can be seen in other papers [14] ; in this paper, we study psychometrics of the current simplified Chinese version of QLQ-C30 (V3.0) using data from a cancer trial consisting of patients with five types of cancer conducted in Mainland China.
materials and methods patients
The study population consisted of inpatients with one of the five types of cancers-lung cancer, breast cancer, colorectal cancer, head and neck cancer, and stomach cancer-in Yunnan Tumor Hospital, at any age, any clinical stage, and any treatments, who can read and understand the questionnaires. The two exclusion criteria were an inability to read the questionnaires because of illiteracy and an inability to fill out the questionnaires because of deteriorated disease. We limited to these five cancers for they have higher prevalence and thus are good representatives of all cancer patients in China.
instruments
The study subjects were assessed by the simplified Chinese version of QLQ-C30 (V3.0) and the quality of life instruments for cancer patients-general module (QLICP-GM). The latter was developed by our research group for use with Chinese cancer patients and was used here to compare the properties of the two instruments.
The QLICP-GM was developed on the basis of QOL as defined by the World Health Organization and on programmed decision procedures, including multiple nominal and focus group discussions and pilot and field tests [15] . It includes 32 items classified into four domains and nine facets, with each item scored on the basis of a five-point Likert scale. The scoring method of this instrument is similar to that of FACT-G [3, 4] (see Table 1 for details). Regarding psychometrics, correlational and structural equation model analyses confirmed good construct validity [15] . The internal consistency a for the domains of physical (PHD), psychological (PSD), social, and common symptom/side-effects, and the overall scale were 0.77, 0.85, 0.61, 0.71, and 0.88, respectively. The test-retest reliability for all domains and the overall scale are >0.85. QOL score changes after treatment were of statistical significance on the three domains of physical, psychological, and common symptoms and side-effects, and the overall instrument with standardized response mean (SRM) ranged from 0.16 to 0.67. Overall, the QLICP-GM has good validity, reliability, and responsiveness and can be used to measure QOL for patients with cancer in China.
collection of data
The simplified Chinese versions of QLQ-C30 and QLICP-GM were administered to a sample of 600 cancer inpatients with five types of cancers 
analysis method
The Chinese version of QLQ-C30 was evaluated for reliability, validity, and responsiveness. Construct validity was evaluated by the Pearson's correlation coefficient, r, among items and domains and by the confirmatory factor analysis using structural equation models. Multi-trait scaling analysis [16] was employed to test item convergent and discriminant validity, with two criteria: (i) convergent validity is supported when an item-domain correlation is ‡0.40 and (ii) discriminant validity is revealed when item-domain correlation is higher than that with other domains. Also, Pearson's correlation coefficients between the QLQ-C30 and the QLICP-GM were calculated to evaluate the criterion-related validity due to the lack of a gold standard. It was hypothesized that conceptually related domains would correlate substantially high with each other. The knowngroups method was used to assess the clinical validity [2] . Internal consistency reliability was evaluated using Cronbach's a coefficient for each domain. Test-retest reliability was evaluated by the Pearson's correlation coefficient between the first and the second assessment, and intraclass correlation (ICC) under the two-way mixed model [17, 18] . Responsiveness was assessed by comparing the mean difference between the first and the third assessments (pre-treatment and post-treatment) using SRM as the computed effect size [19, 20] . It was on the basis of our experience and expectation that QOL scores would change after treatments and good instruments would reflect these changes. All statistical analyses were carried out using SPSS (V13. Table 2 for details).
construct validity
Pearson's correlation and the structural equation model were used to study the construct validity of the instrument. The correlation coefficients among items and multi-item domains showed strong correlations between items and their own domains (all correlation coefficients r are >0.70 with a range of 0.71-0.94). On the other hand, there were weak correlations between items and other domains (see Table 3 ). These also demonstrated item convergent and discriminant validity. 
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Structural equation model analysis showed that the structure of the QLQ-C30 can be grouped into 15 domains (see Table 4 ), with goodness of fit chi-square v 2 = 762.28 (P < 0.0001), root mean square error of approximation (RMSEA) = 0.054, 90% confidence interval = (0.049-0.059), non-normed fit index = 0.972, comparative fit index (CFI) = 0.980, and standardized root mean square residual (SRMR) = 0.037. These indicators demonstrated excellent fitting of data [21, 22] .
criteria-related validity
The QLICP-GM developed by our research group was used as criteria due to the lack of a gold standard. The Pearson's correlation coefficients of scores among domains of two instruments (QLQ-C30 and QLICP-GM) are presented in Table 5 . It can be seen from Table 5 that the betweeninstrument correlations are higher for the same and similar domains than across different and nonsimilar domains. For example, the coefficient between PF of QLQ-C30 and PHD of QLICP-GM is 0.41, higher than that between PF of QLQ-C30 and any other domains of QLICP-GM. Also the correlation between EF and PSD is 0.67, higher than that between EF and any other domains of QLICP-GM.
clinical validity (known-groups validity)
It is well known that a patient's clinical stage can affect QOL. Generally speaking, patients at an earlier stage can be treated by surgery and those at a late stage are often treated by other methods such as chemotherapy. It is expected that the patients who had surgery would have different QOL scores as compared with those who received chemotherapy. Thus, we selected two subgroups of inpatients when they were hospitalized, a surgery group (80 cases) and a chemotherapy group (78 cases), and compared the mean QOL scores between the two treatment groups by t-tests. As shown in Table 5 , there were significant differences for nine out of 15 domains, including almost all of the symptom domains (exception of insomnia and diarrhea). The surgery group had higher QOL than the chemotherapy counterpart on the whole because it had a higher mean score for functioning domains and a lower score for symptom domains. In other words, surgical patients reliability The Cronbach's a and test-retest reliability coefficients (correlation coefficients r and ICC) of all domains are presented in Table 6 . As can be seen in Table 6 , the Cronbach's a coefficients of all domains are >0.7 except for CF (0.49). The test-retest reliability coefficients for most domains are >0.80 except for AP (0.77) and DI (0.75). The paired t-tests indicated no statistically significant change of domain scores between the first and the second measurements (P > 0.05). ICC is very similar to correlation coefficient r, indicating no significant drift in the mean response for all domains.
responsiveness
The third assessment (post-treatment) was completed by 335 patients (breast cancer 94, lung cancer 61, colorectal cancer 54, head and neck cancer 60, and stomach cancer 66). The mean duration of time between pre-and post-treatment assessments was 26.6 6 18.2 days (median = 21.0). Paired t-tests were used to examine changes of mean scores from pre-to post-treatment for each domain of the QLQ-C30. Patients were divided into two groups to analyze responsiveness because the direction of change of QOL after treatment differed across the cancer types; the change was negative for the group of breast and lung cancer, but positive for the group of colorectal, stomach, and head and neck cancer. The results are reported in Tables 7 and 8 , respectively, with the SRM being the difference (absolute value) divided by its standard deviation.
It can be seen from Table 7 that for the breast and lung cancer groups, QOL score changes after treatment were of statistical significance on all domains except for QL, with SRM being >0.50 for all domains except for QL (0.10) and FI (0.28). Table 8 shows that for the colorectal, stomach, and head discussion QLQ-C30 has been used in hundreds of research studies and its psychometric properties have been well documented [2, [10] [11] [12] [13] [14] [23] [24] [25] , including its traditional Chinese version used in Taiwan and Hong Kong [11] [12] [13] . This paper focuses on psychometric properties of the simplified Chinese version used in the Mainland of China. Instrument validity indicates how an instrument can capture what it purports to measure. We used correlational analysis and structural equation models to confirm the construct and criterion-related validity of the QLQ-C30. Multi-trait scaling analysis showed that all item-domain correlation coefficients met the standards of item convergent and discriminant validity. It can be seen from Table 3 that overall the correlations between the same and similar domains of QLQ-C30 and QLICP-GM are higher than those between different and nonsimilar [21] . On the basis of these criteria, it can be seen from Table 4 that the constructs of the instrument are consistent with the original concept, with excellent model fit. Reliability refers to the reproducibility or consistency of scores from one assessment to another. Test-retest reliability (r) and internal consistency (Cronbach's a) are the most frequently used indicators. It is well recognized that internal consistency (a) should be at least 0.70 and reliability (r) should be >0.80 in a test-retest situation [26] . Our results (Table 6) show that the simplified Chinese version of the QLQ-C30 has good reliability, with the exception of a few domains such as CF, AP, and DI.
The most important characteristic of a QOL scale is that it can detect change of QOL after treatments or interventions. Generally speaking, the assessment of responsiveness can be divided into two categories: internal and external [19, 20] . Internal responsiveness characterizes the ability of a measure to change in response to an effective intervention. One widely used method of assessing internal responsiveness is to evaluate the change in a measure within the context of a randomized clinical trial involving a treatment that has previously been shown to be efficacious [27, 28] . External responsiveness reflects the extent to which changes in a measure over a specified time frame relate to corresponding changes in a reference measure of health status. In this paper, we focused on internal responsiveness. The paired t-test was used to compare the change of mean responses between the first and the third assessments (pre-treatment and post-treatment), with the hypothesis that QOL scores would change after treatment. The responsiveness indicator, SRM, was also computed, with values of 0.20, 0.50, and 0.80 proposed to represent small, moderate, and large responsiveness, respectively [19, 20] . Our results showed that QOL score changes after treatment were of statistical significance on most domains for not only the breast and lung cancer groups (Table 7) but also the colorectal, stomach, and head and neck cancer groups (Table 8) . Some possible reasons for the domains with no significant changes are (i) the observation period (4 weeks) may be too short to find significant changes in these domains and (2) some domains have stable scores that simply do not change after treatment, for example, social function (SF) would not be expected to change during hospitalization. Therefore, it can be inferred that this instrument has reasonably good responsiveness and is more sensitive for the first group than for the second group.
From our findings and those in the literature, it can be seen that the psychometric properties of this instrument are very similar to those of the original English version and other language versions [2, 10-14, 23-25, 29, 30] . For example, the Korean version of QLQ-C30 (V3.0) [29] showed that Cronbach's a coefficients for eight multiple-item scales were >0.70, with the exception of cognitive functioning. All interscale correlations were statistically significant in the expected direction (P < 0.01). Multi-trait scaling analyses demonstrated that all scales met multidimensional conceptualization criteria, in terms of convergence and discrimination validity. Silpakit et al. [30] reported that Cronbach's a coefficients of the six scales of the Thai version of QLQ-C30 (V3.0) were >0.7, except for cognitive and social function scales. All test-retest reliability coefficients were high. Multi-trait scaling analysis showed that all item-scale correlation coefficients met the standards of convergent and It is worth noting that the study patients were divided into two groups to analyze responsiveness because the directions of change of QOL scores were not the same after treatment. According to our experience with QOL instruments for these five types of cancer patients as well as empirical evidence from descriptive statistics, QOL scores of many domains decreased after treatment for the patients with breast and lung cancer, while increasing for those with colorectal, stomach, and head and neck cancer. Further investigation is needed to study the underlying mechanisms for such different patterns of change across the different cancer groups. 
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